FILGRASTIM
filgrastim 120 microgram/0.2 mL injection, 10 x 0.2 mL syringes
FILGRASTIM (5829T)
5829T
Body System:
Manner of administration:Injection
Restriction 7822
Indication: Chemotherapy-induced neutropenia
Restriction 7843
Indication: Chemotherapy-induced neutropenia
Restriction 6653
Indication: Mobilisation of peripheral blood progenitor cells
Restriction 6654
Indication: Mobilisation of peripheral blood progenitor cells
Restriction 6679
Indication: Assisting bone marrow transplantation
Restriction 6655
Indication: Assisting autologous peripheral blood progenitor cell transplantation
Restriction 6680
Indication: Severe congenital neutropenia
Restriction 6621
Indication: Severe chronic neutropenia
Restriction 6640
Indication: Chronic cyclical neutropenia
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 20 | # of repeats: 11 | DPMQ: $247.68 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Nivestim | |||||